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Mycobacterium chelonae infections usually resolve with adequate 
therapy. We report the case of an adolescent with a chronic and 
progressive M chelonae infection refractory to combined anti-
microbial and surgical therapy. Whole genome sequence analysis 
of consecutive isolates distinguished reinfection from recurrence 
and contributed to the diagnosis of a factitious disorder.
Keywords.  factitious disorder; Mycobacterium chelonae; 
pediatrics; psychiatry; whole genome sequencing.
A 14-year-old previously healthy female adolescent presented 
with an inflammatory skin lesion of her left lower limb to a 
peripheral emergency center. She stated that the lesion re-
sulted from a trivial wood splinter wound to her left ankle in 
December 2018 with local redness, swelling, and pain (Figure 
1, no. 1;  Supplementary Figure 1). Physical examination was 
otherwise unremarkable. Local incision and wound inspection 
failed to reveal any debris. Bacterial secondary infection was 
suspected.
Amoxicillin/clavulanate was prescribed for 7 days. Six weeks 
later, the patient presented to another emergency center with ad-
ditional lesions located proximally to the primary site. Despite 
restarting amoxicillin/clavulanate, the lesions continued to dete-
riorate. Thus, the patient was referred to our institution 2 months 
after the onset of her illness. On admission, she was afebrile and 
well appearing. Her physical examination was unremarkable 
except for 3 partly confluent, tender, raised, erythematous, and 
poorly demarcated lesions on the medial aspect of the left calf 
(Figure 1, nos. 2 and 3). The skin surface was intact. Her periph-
eral white blood cell count (WBC) was 7.9 × 109/L, C-reactive 
protein (CRP) was <3  mg/L, and the erythrocyte sedimenta-
tion rate was 19 mm/hour. Histopathology of a skin biopsy re-
vealed granulomatous inflammation and a routine culture grew 
Enterobacter cloacae. She was discharged from the hospital 
with oral ciprofloxacin for 7 days. Two weeks later, she was re-
admitted, because her left lower leg lesions progressed (Figure 
1, nos. 3 and 5). She was started on cefepime, the lesions were 
debrided, and vacuum-assisted wound therapy was adminis-
tered for 8  days. Histopathology revealed fibrotic tissue with 
moderate, nonspecific inflammation. Mycobacterial culture 
from a biopsy specimen grew Mycobacterium chelonae (isolate 
MCHE08). The diagnosis of a mycobacterial skin and soft tissue 
infection with a sporotrichoid pattern was made. Oral therapy 
with clarithromycin and moxifloxacin was initiated empiri-
cally. In accordance with the results of the susceptibility testing 
(Supplementary Table 1), the latter was subsequently replaced 
by tobramycin. A right-arm midline catheter was inserted for 
outpatient therapy. Five days later, the patient presented with 
acute-onset fever, chills, and myalgias. Her WBC count was 
13.6 × 109/L, CRP was 26  mg/L, and a peripheral blood cul-
ture grew ɑ-hemolytic streptococci considered irrelevant. Four 
days later, she again presented with fever to 40°C and required 
readmission. Her midline catheter was removed, and she de-
fervesced promptly without additional antimicrobial therapy. 
A blood culture drawn through this line yielded Acinetobacter 
species, Stenotrophomonas maltophilia, and Enterococcus 
faecalis. Two repeat blood cultures within 24 hours as well as the 
catheter tip culture remained sterile. Because of local tender-
ness on her right forearm, Doppler sonography was performed 
and revealed radial vein thrombosis. Subcutaneous enoxaparin 
was initiated and switched to low-dose therapy after 3 weeks for 
a total of 6 weeks. Clarithromycin was continued, tobramycin 
was replaced by oral linezolid.
Two weeks later, a new lesion appeared. The patient was re-
admitted, and the lesion, together with scar tissue from pre-
vious surgery, was removed (Figure 1, no.  5). Microscopy 
revealed acid-fast bacilli, but mycobacterial culture yielded no 
growth. Histology revealed granulomatous, partly necrotizing 
inflammation at multiple biopsy sites. During her 6-day admis-
sion, she received oral clarithromycin and tobramycin, which 
was replaced by clofazimine, when she was discharged. The 
lesions gradually improved during the subsequent 2  months. 
In August 2019, multiple new lesions appeared (Figure 1, 
no. 8), which were initially diagnosed as erythema nodosum. 
These lesions gradually improved over 2  months with topical 
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corticosteroid therapy. In October 2019, yet another erythema 
nodosum-like lesion appeared. Excisional biopsy again revealed 
granulomatous inflammation and mycobacterial culture again 
grew M chelonae (isolate MCHE42), now revealing resistance 
to clarithromycin (Supplementary Table 1), which was replaced 
by minocycline. Comparative deoxyribonucleic acid sequence 
analysis of the of the rrl gene of the 2 available isolates revealed 
the appearance of the point mutation A2059G, which confers 
macrolide resistance presumed to have resulted from prolonged 
clarithromycin exposure. As had first been done 7 months earlier, 
we confronted the patient with our suspicion of self-harm, but 
she denied it. Genomic analysis of the 2 available isolates using 
next-generation whole genome sequencing (WGS) was subse-
quently performed (Supplementary Tables 2–5) and revealed 
that the 2 isolates, MCHE08 and MCHE42, were genetically 
highly diverse and clonally unrelated (Supplementary Figure 2 
and Table 6). The 2 isolates showed some genomic similarities 
and shared identical taxonomic classification as M chelonae, but 
unambiguous differences at both the single-nucleotide variant 
(SNV) and genomic organization level including a plasmid and 
other genomic elements (Supplementary Figure 2) indicated 
that the 2 genomes were evolutionarily unrelated to each other.
At approximately the time when these results became avail-
able, the patient revealed to her psychotherapist, who had fol-
lowed her for the past 5 months, that the lesions appeared after 
multiple intentional self-injuries. She explained that she repeat-
edly self-injected up to 30 mL tap water that had been stagnant 
for weeks at a time in a plastic drinking bottle on the windowsill 
of her bedroom. She presented a “leg map” drawn from memory 
with the approximate injection sites and dates (Figure 1A).
Patient Consent Statement
Oral informed consent was obtained from the patient and her 
family as required by the University Hospital for case reports. 
The Cantonal Ethics Committee, Bern, Switzerland, declared 
nonresponsibility.
DISCUSSION 
Factitious disorders (FDS) are rare, challenging to manage, and 
usually incur long diagnostic delays dotted with unnecessary, 
misleading, and potentially harmful interventions. Factitious 
disorders also occur in children and adolescents [1]. Clinicians 
suspecting factitious behavior induced by the patient or another 
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Figure 1. (A) “Leg map” sketch drawn by the patient and annotated by the authors indicating the approximate dates of self-injection and of spontaneously appearing le-
sions reported by the patient; (B–F) clinical presentation at different time points as indicated, numbers in circles correspond to those in A.
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person (Munchausen syndrome by proxy) often fail to collect 
physical evidence corroborating illness falsification [1] for ex-
tended periods of time. In our case, clinical suspicion arose for 
the first time when polymicrobial, catheter-related bacteremia 
complicated by an arm vein thrombosis occurred 6 months be-
fore FD was finally ascertained.
Self- or proxy-induced infections are a major subgroup of 
FD [1] and often involve skin manifestations [2]. Remarkably, 
nontuberculous mycobacteria (NTM) and, specifically, M 
chelonae have rarely been implicated as pathogens in FD de-
spite being ubiquitous environmental organisms known to 
contaminate soil and water [3]. To our knowledge, only 3 cases 
of FD resulting in NTM infections have been reported, all pre-
senting with bloodstream infections due to Mycobacterium 
mucogenicum [4, 5] or Mycobacterium fortuitum [6]. Thus, this 
report is the first to describe an FD presenting as NTM infec-
tion induced by repetitive self-inoculation of stagnant drinking 
water using a hypodermic needle. It is interesting to note that all 
NTM species previously reported are rapidly growing mycobac-
teria. Factitious panniculitis, presumably with similar clinical 
appearance, was reported as FD induced by cupping or milk 
injections.
We entertained the diagnosis of a naturally evolving and 
relapsing M chelonae infection for many months, because the 
patient adhered reliably to therapy, endured adverse effects, pre-
sented with a seemingly sporotrichoid pattern of progression 
well described for M chelonae infections [7], and experienced 
apparently treatment-related emergence of a rrl gene mutation 
conferring clarithromycin resistance (Supplementary Data). 
Because difficult-to-treat M chelonae infections are primarily 
encountered in immunocompromised patients [8], we even 
planned a diagnostic work-up for genetic Mendelian suscepti-
bility to mycobacterial disease [9].
Genomic comparison of the 2 isolates (MCHE08 and 
MCE42) recovered from 2 distant lesions sampled 7  months 
apart unequivocally established that reinfection rather than re-
lapse had occurred and that clarithromycin resistance did not 
result from a single mutational event in the rrl gene of the orig-
inal isolate, but it reflected the primary genotype of the second 
one. We cannot rule out the possibility that both isolates may 
have been present from the outset rather than sequentially, but 
we expect that we would have identified different strains in cul-
ture and WGS analysis [10]. Genomic comparison revealed that 
the 2 isolates were genetically diverse and clonally unrelated 
(Supplementary Material). This notion is clearly supported by 
clinical studies in Mycobacterium abscessus, a closely related 
species, demonstrating that within-patient isolates typically 
differ by less than 50 SNV [11, 12], which is far less than what 
we observed.
Within-patient WGS has emerged as a precise tool to distin-
guish between relapse and reinfection in patients with tubercu-
losis [13], Mycobacterium ulcerans [14], M abscessus [12], and 
various non-mycobacterial infections. It is also used in forensic 
medicine. However, to our knowledge, it has not been described 
in M chelonae infection or as a diagnostic tool to support the 
diagnosis of FD-associated infection of any etiology. Whole ge-
nome sequencing of M chelonae for other purposes included 
its identification in an outbreak of tattoo infections related to 
contaminated ink and water [15] and in nosocomial infection 
chains complicating cosmetic surgery.
Whole genome sequencing can thus be a powerful tool for 
diagnosing FD as the cause of seemingly chronic infections, but 
several limitations remain. First, establishing plausibility for re-
petitive self-inoculation requires a multidisciplinary approach 
including psychiatric exploration. Molecular diagnostics can 
have an important supportive role for subsequent psycho-
therapy not only by unmasking the pathogenesis, but also by 
fostering lasting confidence in the accuracy of the diagnosis 
of FD. Second, as in any microbiologic analysis, erroneous in-
terpretation of WGS comparison may occur if an isolate is a 
contaminant rather than a pathogen at the sampling site. This 
could easily occur with an environmental organism such as M 
chelonae, but it appears improbable in the present case. Surgical 
sites with intact skin surfaces were sampled, histopathology 
yielded granulomatous inflammation at each site, and WGS 
ruled out a clonal origin of the isolates. Third, distinguishing 
between within-host microevolution and reinfection may not 
always be as obvious as in this case, particularly when the 
number of SNV is small. On the other hand, the identification 
of few genomic differences between consecutive within-host 
isolates cannot be considered as decisive proof against reinfec-
tion by the same environmental isolate. Ultimately, bacterial 
WGS is currently an expensive research tool, and its costs are 
not generally covered by healthcare insurances.
CONCLUSIONS
Comparative genomic analysis using WGS of sequential clin-
ical isolates from a given patient may differentiate between 
relapse and reinfection and provide robust evidence for clin-
ically suspected FD presenting as chronic or recurrent infec-
tion. Sequence analysis of individual antimicrobial resistance 
genes may erroneously indicate treatment-induced emergency 
of resistance when in fact reinfection with a different strain had 
occurred.
Supplementary Data
Supplementary materials are available at Open Forum Infectious Diseases 
online. Consisting of data provided by the authors to benefit the reader, 
the posted materials are not copyedited and are the sole responsibility 
of the authors, so questions or comments should be addressed to the 
corresponding author.
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